Improved three-dimensional free-breathing coronary magnetic resonance angiography using gadocoletic acid (B-22956) for intravascular contrast enhancement

Journal of Magnetic Resonance Imaging

Volumn 20, Issue 2, 2004, Pages 288-293

  Paetsch, Ingo ^a   Huber, Michael E ^b   Bornstedt, Axel ^a   Schnackenburg, Bernhard ^a,c   Boesiger, Peter ^b   Stuber, Matthias ^d   Fleck, Eckart ^a   Cavagna, Friedrich ^e   Nagel, Eike ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b ETH ZURICH   (Switzerland)

^c PHILIPS HEALTHCARE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Bracco Imaging SpA   (Italy)

Author keywords

B 22956; Contrast agents; Coronary artery imaging; Intravascular contrast enhancement; Magnetic resonance imaging

Indexed keywords

B 22956; GADOCOLETIC ACID; GADOLINIUM; UNCLASSIFIED DRUG;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IMAGE QUALITY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEFT CORONARY ARTERY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RADIOLOGICAL PARAMETERS; RIGHT CORONARY ARTERY; THREE DIMENSIONAL IMAGING;

ADULT; CONTRAST MEDIA; CORONARY VESSELS; GADOLINIUM; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; INHALATION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; ORGANOMETALLIC COMPOUNDS;

EID: 3242757471     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.20099     Document Type: Article

References (17)

1. Brittain JH, Hu BS, Wright GA, Meyer CH, Macovski A, Nishimura DG. Coronary angiography with magnetization-prepared T2 contrast. Magn Reson Med 1995;33:689-696.
2. Stuber M, Botnar RM, Danias PG, et al. Double-oblique free-breathing high resolution three-dimensional coronary magnetic resonance angiography. J Am Coll Cardiol 1999;34:524-531.
3. Kim WY, Danias PG, Stuber M, et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 2001;345:1863-1869.
4. Hofman MB, Henson RE, Kovacs SJ, et al. Blood pool agent strongly improves 3D magnetic resonance coronary angiography using an inversion pre-pulse. Magn Reson Med 1999;41:360-367.
5. Cavagna FM, Anelli PL, Lorusso V, et al. B-22956, a new intravascular contrast agent for MR coronary angiography. In: Proceedings of the 9th Annual Meeting of ISMRM, Glasgow, 2001. p 519.
6. Li D, Dolan RP, Walovitch RC, Lauffer RB. Three-dimensional MRI of coronary arteries using an intravascular contrast agent. Magn Reson Med 1998;39:1014-1018.
7. Huber M, Paetsch I, Schnackenburg B, et al. Performance of a new gadolinium-based intravascular contrast agent in free-breathing inversion-recovery 3D coronary MRA. Magn Reson Med 2003;49: 115-121.
8. Fischer SE, Wickline SA, Lorenz CH. Novel real-time R-wave detection algorithm based on the vectorcardiogram for accurate gated magnetic resonance acquisitions. Magn Reson Med 1999;42:361-370.
9. Stuber M, Botnar RM, Danias PG, et al. Contrast agent-enhanced, free-breathing, three-dimensional coronary magnetic resonance angiography. J Magn Reson Imaging 1999;10:790-799.
10. Cavagna FM, La Noce A, Maggioni F, et al. MR coronary angiography with the new intravascular contrast agent B-22956/1: first human experience. In: Proceedings of the 10th Annual Meeting of ISMRM, Honolulu. 2002. p 114.
11. Etienne A, Botnar RM, Van Muiswinkel AM, Boesiger P, Manning WJ, Stuber M. "Soap-bubble" visualization and quantitative analysis of 3D coronary magnetic resonance angiograms. Magn Reson Med 2002;48:658-666.
12. Etienne A, Boesiger P, Manning W, Nagel E, Botnar R, Stuber M. Quantitative coronary analysis and visualization based on three dimensional coronary magnetic resonance angiography [Abstract]. J Cardiovasc Magn Reson 2002;4:90.
13. Botnar RM, Stuber M, Danias PG, Kissinger KV, Manning WJ. Improved coronary artery definition with T2-weighted, free-breathing, three-dimensional coronary MRA. Circulation 1999:99:3139-3148.
14. Regenfus M, Ropers D, Achenbach S, et al. Noninvasive detection of coronary artery stenosis using contrast-enhanced three-dimensional breath-hold magnetic resonance coronary angiography. J Am Coll Cardiol 2000;36:44-50.
15. Li D, Zheng J, Bae KT, Woodard PK, Haacke EM. Contrast-enhanced magnetic resonance imaging of the coronary arteries. A review. Invest Radiol 1998;33:578-586.
16. Taylor AM, Panting JR, Keegan J, et al. Safety and preliminary findings with the intravascular contrast agent NC 100150 injection for MR coronary angiography. J Magn Reson Imaging 1999:9:220-227.
17. Klein C, Nagel E, Schnackenburg B, et al. The intravascular contrast agent Clariscan (NC 100150 injection) for 3D MR coronary angiography in patients with coronary artery disease. MAGMA 2000;11:65-67.